Literature DB >> 17143521

The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer.

Makoto Yamasaki1, Ichiro Takemasa, Takamichi Komori, Shouji Watanabe, Mitsugu Sekimoto, Yuichiro Doki, Kenichi Matsubara, Morito Monden.   

Abstract

The major cause of death in colorectal cancer is related to liver metastasis. Although the metastatic process has been well studied, many aspects of the molecular genetic basis of metastasis remain unclear. Elucidation of the molecular nature of liver metastasis is urgent to improve the outcome of colorectal cancer. We analyzed the chronological gene expression profiles of 104 colorectal samples corresponding to oncogenic development including normal mucosa, localized and metastasized primary tumors, and liver metastatic lesions as fundamental samples using a custom cDNA microarray. The gene expression patterns in 104 samples were classified into four groups closely associated with their metastatic status, and the genes of each group appropriately reflected the metastatic process. To investigate the existence of metastatic potential in primary tumors using metastasis-related genes detected by chronological analysis, we performed a hierarchical cluster and supervised classification analysis of 28 independent primary tumors. Hierarchical cluster analysis segregated the tumors according to their final metastatic status, rather than their clinical stages, and the profile of metastasized primary tumors resembled one of a metastatic lesion apart from a primary lesion rather than one of a non-metastasized primary tumor. Using the supervised classification approach, the expression profile of these genes allowed the classification of tumors diagnosed as localized cancer into two classes, the localized and the metastasized class, according to their final metastatic status. The disease-free survival and overall survival were significantly longer in the localized class than the metastasized class. Chronological analysis of the gene expression profile provides a better understanding of the metastatic process. Our results suggest that the metastatic potential is already encoded in the primary tumor and is detectable by a gene expression profile, which allows the prediction of liver metastasis in patients diagnosed with localized tumors and also the design of new strategies for the treatment and diagnosis of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143521

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  20 in total

1.  A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress.

Authors:  Peter M Bruno; Yunpeng Liu; Ga Young Park; Junko Murai; Catherine E Koch; Timothy J Eisen; Justin R Pritchard; Yves Pommier; Stephen J Lippard; Michael T Hemann
Journal:  Nat Med       Date:  2017-02-27       Impact factor: 53.440

2.  Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer.

Authors:  Robert N Jorissen; Peter Gibbs; Michael Christie; Saurabh Prakash; Lara Lipton; Jayesh Desai; David Kerr; Lauri A Aaltonen; Diego Arango; Mogens Kruhøffer; Torben F Orntoft; Claus Lindbjerg Andersen; Mike Gruidl; Vidya P Kamath; Steven Eschrich; Timothy J Yeatman; Oliver M Sieber
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

3.  Identification of Systems Level Molecular Signatures from Glioblastoma Multiforme Derived Extracellular Vesicles.

Authors:  Nabanita Roy; Mithil Gaikwad; Dhruba Kr Bhattacharrya; Pankaj Barah
Journal:  J Mol Neurosci       Date:  2020-11-24       Impact factor: 3.444

4.  Impact of chromosome 17q deletion in the primary lesion of colorectal cancer on liver metastasis.

Authors:  Masaya Kawai; Hiromitsu Komiyama; Masaki Hosoya; Haruna Okubo; Tomoaki Fujii; Norihiko Yokoyama; Chiyo Sato; Takae Ueyama; Atsushi Okuzawa; Michitoshi Goto; Yutaka Kojima; Makoto Takahashi; Kiichi Sugimoto; Shun Ishiyama; Shinya Munakata; Dai Ogura; Shin-Ichiro Niwa; Yuichi Tomiki; Takumi Ochiai; Kazuhiro Sakamoto
Journal:  Oncol Lett       Date:  2016-10-17       Impact factor: 2.967

5.  The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation.

Authors:  Fernando Vidal-Vanaclocha
Journal:  Cancer Microenviron       Date:  2011-08-26

6.  Gene expression differences between colon and rectum tumors.

Authors:  Rebeca Sanz-Pamplona; David Cordero; Antonio Berenguer; Flavio Lejbkowicz; Hedy Rennert; Ramon Salazar; Sebastiano Biondo; Xavier Sanjuan; Miguel A Pujana; Laura Rozek; Thomas J Giordano; Ofer Ben-Izhak; Hector I Cohen; Philip Trougouboff; Jacob Bejhar; Yanina Sova; Gad Rennert; Stephen B Gruber; Victor Moreno
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

7.  CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-β receptors in colorectal cancer.

Authors:  Xue-Li Zhang; Li-Peng Hu; Qin Yang; Wei-Ting Qin; Xu Wang; Chun-Jie Xu; Guang-Ang Tian; Xiao-Mei Yang; Lin-Li Yao; Lei Zhu; Hui-Zhen Nie; Qing Li; Qing Xu; Zhi-Gang Zhang; Yan-Li Zhang; Jun Li; Ya-Hui Wang; Shu-Heng Jiang
Journal:  Oncogene       Date:  2021-05-13       Impact factor: 9.867

Review 8.  Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.

Authors:  Rebeca Sanz-Pamplona; Antoni Berenguer; David Cordero; Samantha Riccadonna; Xavier Solé; Marta Crous-Bou; Elisabet Guinó; Xavier Sanjuan; Sebastiano Biondo; Antonio Soriano; Giuseppe Jurman; Gabriel Capella; Cesare Furlanello; Victor Moreno
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior.

Authors:  Beatriz Perez-Villamil; Alejandro Romera-Lopez; Susana Hernandez-Prieto; Guillermo Lopez-Campos; Antonio Calles; Jose-Antonio Lopez-Asenjo; Julian Sanz-Ortega; Cristina Fernandez-Perez; Javier Sastre; Rosario Alfonso; Trinidad Caldes; Fernando Martin-Sanchez; Eduardo Diaz-Rubio
Journal:  BMC Cancer       Date:  2012-06-19       Impact factor: 4.430

10.  Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.

Authors:  N Miyoshi; H Ishii; K Mimori; Y Takatsuno; H Kim; H Hirose; M Sekimoto; Y Doki; M Mori
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.